Adrian Ciurea - Concepedia

Author

Adrian Ciurea

University Hospital of Zurich ORCID

Also Known As

A Ciurea, A M Ciurea, A. Ciurea, Adrian Ciurea, Ciurea, Ciurea, A., Ciurea, Adrian

228

Publications

Citations

H-Index

Concepts

All Affiliations

University Hospital of Zurich University Hospital of Geneva University of Zurich University Hospital of Bern SCQM Foundation

About

Adrian Ciurea is an author at University Hospital of Zurich specializing in medicine, immunology, and rheumatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	733
2	Health Sciences	1	1	95
3	Public Health	1	1	53
4	Allergy	1	1	79
5	Cell Biology	1	1	33

Adrian Ciurea

Publications

Citations

H-Index

Page 1

	Year	Citations
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update Sofía Ramiro, Elena Nikiphorou, Alexandre Sepriano, Annals of the Rheumatic Diseases	2022	808
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort Christoph Molnar, Almut Scherer, Xenofon Baraliakos, Annals of the Rheumatic Diseases	2017	249
Hypergammaglobulinemia and autoantibody induction mechanisms in viral infections Lukas Hunziker, Mike Recher, Andrew J. Macpherson, Nature Immunology Viral PersistenceAutoimmune DiseasePathogenesisImmunologyVirology	2003	233
Comparison of drug retention rates and causes of drug discontinuation between anti–tumor necrosis factor agents in rheumatoid arthritis Sophie Martin Du Pan, Silvia Dehler, Adrian Ciurea, Arthritis Care & Research	2009	209
B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents Axel Finckh, Adrian Ciurea, Laure Brulhart, Arthritis & Rheumatism	2007	209
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent? Axel Finckh, Adrian Ciurea, Laure Brulhart, Annals of the Rheumatic Diseases	2009	163
Tumor Necrosis Factor α Inhibition in Radiographic and Nonradiographic Axial Spondyloarthritis: Results From a Large Observational Cohort Adrian Ciurea, Almut Scherer, Pascale Exer, Arthritis & Rheumatism	2013	149
Viral persistence<i>in vivo</i>through selection of neutralizing antibody-escape variants Adrian Ciurea, Paul Klenerman, Lukas Hunziker, Proceedings of the National Academy of Sciences	2000	146
Delays in assessment of patients with rheumatoid arthritis: variations across Europe Karim Raza, Rebecca Stack, Kanta Kumar, Annals of the Rheumatic Diseases	2011	146
Tolerance and effectiveness of anti–tumor necrosis factor α therapies in elderly patients with rheumatoid arthritis: A population‐based cohort study Stéphane Genevay, Axel Finckh, Adrian Ciurea, Arthritis Care & Research	2007	121

Page 1